版本:
中国

BRIEF-Abeona Therapeutics publishes preclinical data on MPS IIIA gene therapy

Sept 15 Abeona Therapeutics Inc

* Abeona Therapeutics announces publication of preclinical data supporting clinical translation of MPS IIIA gene therapy

* Early biopotency signals seen in ongoing AB0-102 Phase 1/2 clinical trial directionally consistent with data seen in pre-clinical models of MPS IIIA disease Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐